2,300 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,300 shares of the company’s stock, valued at approximately $78,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Operose Advisors LLC acquired a new position in Tempus AI during the 4th quarter worth about $25,000. Farther Finance Advisors LLC bought a new stake in Tempus AI during the 4th quarter worth about $34,000. Prestige Wealth Management Group LLC raised its holdings in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares during the last quarter. NewEdge Advisors LLC bought a new stake in Tempus AI during the 4th quarter worth about $49,000. Finally, First Horizon Advisors Inc. raised its holdings in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock worth $55,000 after purchasing an additional 1,108 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on TEM shares. Guggenheim reissued a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Wolfe Research cut Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. Piper Sandler boosted their price objective on Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, May 15th. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and boosted their price objective for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Finally, Morgan Stanley upped their price target on Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and a consensus target price of $63.42.

Insider Activity at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 6,073 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total transaction of $383,995.79. Following the completion of the transaction, the chief accounting officer now directly owns 47,799 shares of the company’s stock, valued at $3,022,330.77. This trade represents a 11.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Andrew Polovin sold 13,135 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total transaction of $603,947.30. Following the transaction, the executive vice president now directly owns 154,171 shares of the company’s stock, valued at $7,088,782.58. This represents a 7.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 723,042 shares of company stock worth $37,642,690. 27.60% of the stock is owned by company insiders.

Tempus AI Price Performance

Shares of TEM opened at $54.58 on Monday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock has a 50 day simple moving average of $52.07 and a 200 day simple moving average of $51.75. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The firm has a market capitalization of $9.45 billion and a PE ratio of -7.00.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. The company’s revenue was up 75.4% on a year-over-year basis. Sell-side analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.